Nasopharyngeal carcinoma
Conditions
Interventions
Gold Standard:Target volume used for clinical radiotherapy
Index test:DSC HD95
Sponsors
Sichuan Cancer Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1) No gender limit, age ranges from 18 to 75 years old; 2) Newly treated nasopharyngeal carcinoma confirmed by histology or cytology; 3) Patients who plan to undergo radical radiotherapy and have completed target area delineation; 4) Patients who have both positioning CT and enhanced MRI within a week when delineating the target area; 5) Can understand this research.
Exclusion criteria
Exclusion criteria: 1) When delineating the target area, positioning CT and MRI were not fused and delineated simultaneously in TPS; 2) Patients whose target area has not been delineated or reviewed by a senior physician (deputy chief physician or above); 3) Patients whose MRI image quality is too poor will affect the delineation of the target area.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| DSC;HD95;ASD;Delineating time;Accuracy ;Specificity ;Positive predicative value; | — |
Secondary
| Measure | Time frame |
|---|---|
| Negative predictive value; | — |
Countries
China
Contacts
Public ContactWenjun Liao
Sichuan Cancer Hospital
Outcome results
None listed